Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Minimizing potential resistance: a population dynamics view.

B R Levin1

  • 1Department of Biology, Emory University, Atlanta, GA 30322, USA. blevin@emory.edu

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|August 29, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A methodology for using Lambda phages as a proxy for pathogen transmission in hospitals.

The Journal of hospital infection·2023
Same author

Cardiomyopathy in muscular dystrophy.

QJM : monthly journal of the Association of Physicians·2017
Same author

AIDS as a population-dynamic-evolutionary process.

Trends in ecology & evolution·2011
Same author

Evaluating the risk of releasing genetically engineered organisms.

Trends in ecology & evolution·2011
Same author

Episodic selection and the maintenance of competence and natural transformation in Bacillus subtilis.

Genetics·2009
Same author

Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations.

Antimicrobial agents and chemotherapy·2005
Same journal

Anticalcitonin: Limited utility of a context-dependent biomarker demonstrated in another real-world data set.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Procalcitonin Testing in Community-Acquired Pneumonia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Wanted: A Relevant Correlate of Protection for Dengue Vaccines.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Safety and Immunogenicity of the Live-Attenuated Quadrivalent Dengue Vaccine V181 Compared With Butantan-DV Among Healthy Adults in Brazil: A Randomized, Double-Blind, Phase 2 Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Low Post-Treatment Recurrence After a Shortened All-oral Regimen for Pulmonary Rifampicin- or Multidrug-Resistant Tuberculosis in Individuals without Prior Second-Line Drug Exposure in Kazakhstan.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Sepsis Diagnostic Excellence and its Association with Mortality in Adults with Potential Infection.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles

Mathematical models show antibiotic resistance reduction is slow in communities but rapid in hospitals. Prudent antibiotic use alone takes years for community resistance decline, while hospital interventions can quickly reduce resistant bacteria.

Area of Science:

  • Epidemiology
  • Population Genetics
  • Mathematical Modeling
  • Antimicrobial Resistance

Background:

  • Antibiotic resistance poses a significant threat in both community and hospital settings.
  • Understanding the dynamics of resistance requires analyzing factors like antibiotic consumption and bacterial genetics.
  • Mathematical models are crucial tools for studying complex epidemiological patterns.

Purpose of the Study:

  • To investigate the link between antibiotic consumption and the prevalence of antibiotic resistance.
  • To explore strategies for controlling the spread and persistence of antibiotic resistance.
  • To determine the feasibility and timeline for implementing resistance control measures.

Main Methods:

  • Utilized mathematical modeling of antibiotic treatment and resistance dynamics.

Related Experiment Videos

  • Analyzed data from studies conducted in open communities and hospital environments.
  • Modeled the epidemiology and population genetics of bacterial resistance.

    • Main Results:

    • Significant reductions in community antibiotic resistance through reduced antibiotic use alone may require years to decades.
    • Hospitals can achieve rapid reductions in antibiotic resistance, potentially eliminating resistant bacteria quickly.
    • Restricting the introduction of resistant bacteria into hospitals is key for effective control.

    Conclusions:

    • Implementing infection control measures to limit resistant bacteria entry into hospitals is highly effective.
    • Community-level resistance control via prudent antibiotic use is a long-term strategy.
    • Differentiated strategies are needed for managing antibiotic resistance in community versus hospital settings.